CY1124139T1 - Μη επεμβατικος προσδιορισμος μεθυλωματος ογκου απο πλασμα - Google Patents
Μη επεμβατικος προσδιορισμος μεθυλωματος ογκου απο πλασμαInfo
- Publication number
- CY1124139T1 CY1124139T1 CY20211100417T CY211100417T CY1124139T1 CY 1124139 T1 CY1124139 T1 CY 1124139T1 CY 20211100417 T CY20211100417 T CY 20211100417T CY 211100417 T CY211100417 T CY 211100417T CY 1124139 T1 CY1124139 T1 CY 1124139T1
- Authority
- CY
- Cyprus
- Prior art keywords
- methylation
- dna
- fetal
- tumor
- profile
- Prior art date
Links
- 230000011987 methylation Effects 0.000 abstract 10
- 238000007069 methylation reaction Methods 0.000 abstract 10
- 206010028980 Neoplasm Diseases 0.000 abstract 5
- 230000001605 fetal effect Effects 0.000 abstract 3
- 210000001161 mammalian embryo Anatomy 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 108700028369 Alleles Proteins 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000008774 maternal effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2523/00—Reactions characterised by treatment of reaction samples
- C12Q2523/10—Characterised by chemical treatment
- C12Q2523/125—Bisulfite(s)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
- C12Q2535/122—Massive parallel sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261703512P | 2012-09-20 | 2012-09-20 | |
| US13/842,209 US9732390B2 (en) | 2012-09-20 | 2013-03-15 | Non-invasive determination of methylome of fetus or tumor from plasma |
| US201361830571P | 2013-06-03 | 2013-06-03 | |
| EP13838770.9A EP2898100B9 (en) | 2012-09-20 | 2013-09-20 | Non-invasive determination of methylome of fetus or tumor from plasma |
| PCT/AU2013/001088 WO2014043763A1 (en) | 2012-09-20 | 2013-09-20 | Non-invasive determination of methylome of fetus or tumor from plasma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1124139T1 true CY1124139T1 (el) | 2022-05-27 |
Family
ID=50340462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20211100417T CY1124139T1 (el) | 2012-09-20 | 2021-05-14 | Μη επεμβατικος προσδιορισμος μεθυλωματος ογκου απο πλασμα |
Country Status (28)
| Country | Link |
|---|---|
| EP (6) | EP3536807B1 (enExample) |
| JP (6) | JP6317354B2 (enExample) |
| KR (5) | KR102307424B1 (enExample) |
| CN (2) | CN117757932A (enExample) |
| AU (5) | AU2013317708C1 (enExample) |
| BR (3) | BR122021021823B1 (enExample) |
| CA (2) | CA2884066C (enExample) |
| CY (1) | CY1124139T1 (enExample) |
| DK (4) | DK4056712T3 (enExample) |
| EA (1) | EA201500327A1 (enExample) |
| ES (5) | ES3060911T3 (enExample) |
| FI (2) | FI3536807T3 (enExample) |
| HR (3) | HRP20240210T1 (enExample) |
| HU (3) | HUE053822T2 (enExample) |
| IL (4) | IL313451A (enExample) |
| LT (2) | LT3354747T (enExample) |
| MX (1) | MX360034B (enExample) |
| MY (2) | MY187444A (enExample) |
| NZ (2) | NZ717423A (enExample) |
| PH (2) | PH12022552061A1 (enExample) |
| PL (5) | PL4056712T3 (enExample) |
| PT (4) | PT4056712T (enExample) |
| SG (2) | SG11201501927VA (enExample) |
| SI (1) | SI4056712T1 (enExample) |
| SM (1) | SMT202100256T1 (enExample) |
| TW (6) | TWI784258B (enExample) |
| WO (1) | WO2014043763A1 (enExample) |
| ZA (1) | ZA201501772B (enExample) |
Families Citing this family (98)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101153336B (zh) | 2006-09-27 | 2011-09-07 | 香港中文大学 | 检测dna甲基化程度的方法和试剂盒 |
| US9892230B2 (en) | 2012-03-08 | 2018-02-13 | The Chinese University Of Hong Kong | Size-based analysis of fetal or tumor DNA fraction in plasma |
| US10706957B2 (en) | 2012-09-20 | 2020-07-07 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of tumor from plasma |
| HUE053822T2 (hu) | 2012-09-20 | 2021-07-28 | Univ Hong Kong Chinese | Nem invazív módszer daganat metilom meghatározása plazmából |
| US9732390B2 (en) | 2012-09-20 | 2017-08-15 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of fetus or tumor from plasma |
| US20130309666A1 (en) | 2013-01-25 | 2013-11-21 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| ES2685893T3 (es) * | 2013-07-30 | 2018-10-15 | Bgi Genomics Co., Limited | Método para determinar la composición de ácidos nucleicos de una mezcla de ácidos nucleicos |
| US10174375B2 (en) * | 2013-09-20 | 2019-01-08 | The Chinese University Of Hong Kong | Sequencing analysis of circulating DNA to detect and monitor autoimmune diseases |
| WO2015126840A1 (en) * | 2014-02-18 | 2015-08-27 | Bionano Genomics, Inc. | Improved methods of determining nucleic acid structural information |
| US12492429B2 (en) | 2014-04-21 | 2025-12-09 | Natera, Inc. | Detecting mutations and ploidy in chromosomal segments |
| RU2717641C2 (ru) * | 2014-04-21 | 2020-03-24 | Натера, Инк. | Обнаружение мутаций и плоидности в хромосомных сегментах |
| EP2942400A1 (en) | 2014-05-09 | 2015-11-11 | Lifecodexx AG | Multiplex detection of DNA that originates from a specific cell-type |
| US10801067B2 (en) | 2014-05-09 | 2020-10-13 | Eurofins Lifecodexx Gmbh | Detection of DNA that originates from a specific cell-type and related methods |
| TWI758011B (zh) | 2014-07-18 | 2022-03-11 | 香港中文大學 | Ｄｎａ混合物中之組織甲基化模式分析 |
| WO2016010401A1 (ko) * | 2014-07-18 | 2016-01-21 | 에스케이텔레콘 주식회사 | 산모의 혈청 dna를 이용한 태아의 단일유전자 유전변이의 예측방법 |
| CN107002122B (zh) | 2014-07-25 | 2023-09-19 | 华盛顿大学 | 确定导致无细胞dna的产生的组织和/或细胞类型的方法以及使用其鉴定疾病或紊乱的方法 |
| WO2016109452A1 (en) | 2014-12-31 | 2016-07-07 | Guardant Health , Inc. | Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results |
| US10364467B2 (en) | 2015-01-13 | 2019-07-30 | The Chinese University Of Hong Kong | Using size and number aberrations in plasma DNA for detecting cancer |
| DK3256605T3 (da) * | 2015-02-10 | 2022-03-14 | Univ Hong Kong Chinese | Påvisning af mutationer til cancerscreening og føtal analyse |
| WO2017012544A1 (en) * | 2015-07-20 | 2017-01-26 | The Chinese University Of Hong Kong | Methylation pattern analysis of haplotypes in tissues in dna mixture |
| US10453556B2 (en) * | 2015-07-23 | 2019-10-22 | The Chinese University Of Hong Kong | Analysis of fragmentation patterns of cell-free DNA |
| US11319586B2 (en) | 2015-08-12 | 2022-05-03 | The Chinese University Of Hong Kong | Single-molecule sequencing of plasma DNA |
| MY199897A (en) | 2015-09-22 | 2023-11-28 | Univ Hong Kong Chinese | Accurate quantification of fetal dna fraction by shallow-depth sequencing of maternal plasma dna |
| US10260088B2 (en) * | 2015-10-30 | 2019-04-16 | New England Biolabs, Inc. | Compositions and methods for analyzing modified nucleotides |
| EP4180532A1 (en) * | 2015-11-09 | 2023-05-17 | Roche Molecular Systems, Inc. | Methods for determining the origin of dna molecules |
| HUE050491T2 (hu) | 2015-11-10 | 2020-12-28 | Eurofins Lifecodexx Gmbh | Magzati kromoszomális aneuploidiák kimutatása olyan DNS régiókat alkalmazva, amelyek különbözõképpen vannak metilezve a magzat és a terhes nõstény között |
| CA3168463A1 (en) * | 2015-12-17 | 2017-06-22 | Illumina, Inc. | Distinguishing methylation levels in complex biological samples |
| EP4779643A2 (en) * | 2016-02-02 | 2026-07-22 | Guardant Health, Inc. | Cancer evolution detection and diagnostic |
| US11514289B1 (en) | 2016-03-09 | 2022-11-29 | Freenome Holdings, Inc. | Generating machine learning models using genetic data |
| WO2017181146A1 (en) * | 2016-04-14 | 2017-10-19 | Guardant Health, Inc. | Methods for early detection of cancer |
| US11078475B2 (en) | 2016-05-03 | 2021-08-03 | Sinai Health System | Methods of capturing cell-free methylated DNA and uses of same |
| CA3023335A1 (en) * | 2016-05-04 | 2017-11-30 | Queen's University At Kingston | Cell-free detection of methylated tumour dna |
| CN115161390B (zh) | 2016-05-30 | 2025-12-05 | 香港中文大学 | 使用血液中的无细胞dna检测血液病症 |
| WO2017218908A2 (en) * | 2016-06-16 | 2017-12-21 | The Johns Hopkins University | Methods and system for epigenetic analysis |
| CN107779485B (zh) * | 2016-08-24 | 2022-03-18 | 中国科学院分子细胞科学卓越创新中心 | Cmd1酶催化的5-甲基胞嘧啶核酸的新修饰及其应用 |
| EP4209598A1 (en) | 2016-10-19 | 2023-07-12 | The Chinese University of Hong Kong | Gestational age assessment by methylation and size profiling of maternal plasma dna |
| TWI797095B (zh) | 2016-10-24 | 2023-04-01 | 美商格瑞爾有限責任公司 | 腫瘤檢測之方法及系統 |
| IL266347B2 (en) * | 2016-11-30 | 2025-01-01 | Univ Hong Kong Chinese | Analysis of cell-free DNA in urine and other samples |
| US20190309374A1 (en) * | 2016-12-13 | 2019-10-10 | Bellwether Bio, Inc. | Determining a physiological condition in an individual by analyzing cell-free dna fragment endpoints in a biological sample |
| MX2019008320A (es) * | 2017-01-11 | 2019-09-09 | Quest Diagnostics Invest Llc | Metodo para la deteccion prenatal no invasiva de aneuploidia. |
| ES2981092T3 (es) * | 2017-01-24 | 2024-10-07 | Bgi Genomics Co Ltd | Procedimiento para determinar la proporción de ácidos nucleicos acelulares procedentes de una fuente predeterminada en una muestra biológica |
| WO2018137685A1 (en) | 2017-01-25 | 2018-08-02 | The Chinese University Of Hong Kong | Diagnostic applications using nucleic acid fragments |
| CN107247873B (zh) * | 2017-03-29 | 2020-04-14 | 电子科技大学 | 一种差异甲基化位点识别方法 |
| CN111417731A (zh) * | 2017-05-12 | 2020-07-14 | 哈佛学院校长同事会 | 通用早期癌症诊断 |
| US12227737B2 (en) | 2017-07-12 | 2025-02-18 | University Health Network | Cancer detection and classification using methylome analysis |
| CA3069668A1 (en) * | 2017-07-12 | 2019-01-17 | Ande Corporation | Pattern recognition system |
| KR102628878B1 (ko) * | 2017-07-12 | 2024-01-23 | 유니버시티 헬스 네트워크 | 메틸롬 분석을 이용한 암 검출 및 분류 |
| WO2019020057A1 (en) | 2017-07-26 | 2019-01-31 | The Chinese University Of Hong Kong | ENHANCING CANCER SCREENING WITH ACELLULAR VIRAL NUCLEIC ACIDS |
| US20200263170A1 (en) | 2017-09-14 | 2020-08-20 | Grail, Inc. | Methods for preparing a sequencing library from single-stranded dna |
| WO2019067973A1 (en) | 2017-09-28 | 2019-04-04 | Grail, Inc. | ENRICHMENT OF SHORT NUCLEIC ACID FRAGMENTS IN THE PREPARATION OF SEQUENCING LIBRARIES |
| US11168356B2 (en) | 2017-11-02 | 2021-11-09 | The Chinese University Of Hong Kong | Using nucleic acid size range for noninvasive cancer detection |
| CN111989407B (zh) | 2018-03-13 | 2024-10-29 | 格里尔公司 | 异常的片段检测及分类 |
| AU2019233897B2 (en) * | 2018-03-15 | 2024-10-24 | Grail, Inc. | Tissue-specific methylation marker |
| CA3302676A1 (en) | 2018-04-02 | 2026-05-13 | Grail, Inc. | Methylation markers and targeted methylation probe panels |
| WO2019200410A1 (en) * | 2018-04-13 | 2019-10-17 | Freenome Holdings, Inc. | Machine learning implementation for multi-analyte assay of biological samples |
| CN121137125A (zh) * | 2018-04-16 | 2025-12-16 | 格里尔公司 | 用于确定在无细胞核酸中的肿瘤分数的系统及方法 |
| WO2019209884A1 (en) | 2018-04-23 | 2019-10-31 | Grail, Inc. | Methods and systems for screening for conditions |
| US11932899B2 (en) * | 2018-06-07 | 2024-03-19 | 10X Genomics, Inc. | Methods and systems for characterizing nucleic acid molecules |
| CN109448789A (zh) * | 2018-09-17 | 2019-03-08 | 上海派森诺生物科技股份有限公司 | 一种基于perl语言的种群特异SNP位点的自动化分析方法 |
| EP3856903A4 (en) | 2018-09-27 | 2022-07-27 | Grail, LLC | METHYLATION MARKER AND TARGETED METHYLATION PROBE PANEL |
| CN109295230A (zh) * | 2018-10-24 | 2019-02-01 | 福建翊善生物科技有限公司 | 一种基于ctDNA的多基因联合突变检测评估肿瘤动态变化的方法 |
| AU2019384154B2 (en) | 2018-11-21 | 2025-11-20 | Agilent Technologies, Inc. | Methods for targeted nucleic acid library formation |
| CN113366122B (zh) * | 2018-12-19 | 2024-01-12 | 香港中文大学 | 游离dna末端特征 |
| EP3899953A1 (en) | 2018-12-21 | 2021-10-27 | Grail, Inc. | Source of origin deconvolution based on methylation fragments in cell-free-dna samples |
| WO2020163410A1 (en) | 2019-02-05 | 2020-08-13 | Grail, Inc. | Detecting cancer, cancer tissue of origin, and/or a cancer cell type |
| ES2994567T3 (en) | 2019-02-05 | 2025-01-27 | Grail Inc | Detecting cancer, cancer tissue of origin, and/or a cancer cell type |
| TWI874374B (zh) | 2019-03-25 | 2025-03-01 | 香港中文大學 | 確定循環核酸之線性及環狀形式 |
| US11773450B2 (en) | 2019-04-03 | 2023-10-03 | Grail, Llc | Methylation-based false positive duplicate marking reduction |
| AU2020268885B2 (en) * | 2019-05-03 | 2026-06-11 | Cornell University | Markers for identifying and quantifying of nucleic acid sequence mutation, expression, splice variant, translocation, copy number, or methylation changes |
| KR102452413B1 (ko) * | 2019-08-19 | 2022-10-11 | 주식회사 지씨지놈 | 핵산 단편간 거리 정보를 이용한 염색체 이상 검출 방법 |
| JP7859967B2 (ja) * | 2019-08-19 | 2026-05-15 | グリーン クロス ゲノム コーポレーション | 核酸断片間距離情報を用いた染色体異常検出方法 |
| EP3795685A1 (en) | 2019-09-20 | 2021-03-24 | Sophia Genetics S.A. | Methods for dna library generation to facilitate the detection and reporting of low frequency variants |
| GB201915469D0 (en) | 2019-10-24 | 2019-12-11 | Univ London | Cancer detection methods |
| WO2021108654A1 (en) * | 2019-11-27 | 2021-06-03 | Grail, Inc. | Systems and methods for evaluating longitudinal biological feature data |
| CN115103909A (zh) | 2020-01-31 | 2022-09-23 | 艾维达生物医学公司 | 用于靶向核酸捕获的系统和方法 |
| CN115398007A (zh) * | 2020-02-10 | 2022-11-25 | 帕洛根公司 | 纳米孔装置和使用其检测和分类带电粒子的方法 |
| US11475981B2 (en) | 2020-02-18 | 2022-10-18 | Tempus Labs, Inc. | Methods and systems for dynamic variant thresholding in a liquid biopsy assay |
| US11211144B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Methods and systems for refining copy number variation in a liquid biopsy assay |
| US11211147B2 (en) | 2020-02-18 | 2021-12-28 | Tempus Labs, Inc. | Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing |
| WO2021174072A1 (en) * | 2020-02-28 | 2021-09-02 | Grail, Inc. | Identifying methylation patterns that discriminate or indicate a cancer condition |
| CN112662764A (zh) * | 2020-03-17 | 2021-04-16 | 博尔诚（北京）科技有限公司 | 一种检测11种癌症的探针组合物 |
| US12592321B2 (en) | 2020-06-19 | 2026-03-31 | University Health Network | Cancer detection and classification using methylome analysis |
| RU2738675C1 (ru) * | 2020-07-28 | 2020-12-15 | Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") | Способ прогнозирования риска развития преэклампсии у женщин без отягощенного семейного анамнеза с учетом генетических факторов |
| AU2021384324A1 (en) * | 2020-11-19 | 2023-06-22 | Nucleix Ltd. | Detecting methylation changes in dna samples using restriction enzymes and high throughput sequencing |
| WO2022133315A1 (en) * | 2020-12-17 | 2022-06-23 | President And Fellows Of Harvard College | Methods of cancer detection using extraembryonically methylated cpg islands |
| CN112813148A (zh) * | 2021-02-02 | 2021-05-18 | 博淼生物科技（北京）有限公司 | 飞行时间质谱检测5-羟甲基胞嘧啶的方法 |
| CN118302816A (zh) * | 2021-09-28 | 2024-07-05 | 行动基因(智财)有限公司 | 甲基化生物标记选择装置及方法 |
| KR20230059423A (ko) * | 2021-10-26 | 2023-05-03 | 주식회사 지씨지놈 | 메틸화된 무세포 핵산을 이용한 암 진단 및 암 종 예측방법 |
| CN118215743A (zh) * | 2021-11-04 | 2024-06-18 | 通用诊断股份公司 | 用于制备用于基因测序的生物样品的系统和方法 |
| GB2636509B (en) | 2022-02-07 | 2026-02-18 | Centre For Novostics | Fragmentation for measuring methylation and disease |
| US20240150840A1 (en) * | 2022-02-22 | 2024-05-09 | Flagship Pioneering Innovations Vi, Llc | Intra-individual analysis for presence of health conditions |
| CN115064211B (zh) * | 2022-08-15 | 2023-01-24 | 臻和(北京)生物科技有限公司 | 一种基于全基因组甲基化测序的ctDNA预测方法及装置 |
| CN115612723B (zh) * | 2022-09-26 | 2023-07-14 | 广州女娲生命科技有限公司 | 植入前胚胎的筛选方法 |
| EP4623107A4 (en) * | 2022-11-23 | 2026-03-11 | Found Medicine Inc | CUSTOMIZED METHYLATION BIOMARKER MONITORING SYSTEMS AND METHODS FOR DISEASE DETECTION |
| WO2024203348A1 (ja) * | 2023-03-31 | 2024-10-03 | ソニーグループ株式会社 | 腫瘍の解析方法、腫瘍の解析システム、及び腫瘍の解析データ生成方法 |
| CN118737268A (zh) * | 2023-05-04 | 2024-10-01 | 杭州圣庭医疗科技有限公司 | 一种鉴定肿瘤组织来源的试剂盒的数据分析方法 |
| CN117025753A (zh) * | 2023-08-15 | 2023-11-10 | 广州女娲生命科技有限公司 | 检测染色体变异的方法和装置 |
| CN117079822B (zh) * | 2023-10-17 | 2024-01-02 | 北京大学第三医院（北京大学第三临床医学院） | 一种妊娠早中期四因子预测胎儿脑损伤的系统 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6927028B2 (en) | 2001-08-31 | 2005-08-09 | Chinese University Of Hong Kong | Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA |
| DK1342794T3 (da) † | 2002-03-05 | 2006-04-24 | Epigenomics Ag | Fremgangsmåde og anordning til at bestemme vævsspecificitet af fritflydende DNA i legemsvæsker |
| EP1570081A4 (en) * | 2002-11-19 | 2006-05-31 | Amgen Inc | AMPLIFIED GENES INVOLVED IN CANCER |
| US20060183128A1 (en) † | 2003-08-12 | 2006-08-17 | Epigenomics Ag | Methods and compositions for differentiating tissues for cell types using epigenetic markers |
| DE10348407A1 (de) | 2003-10-17 | 2005-05-19 | Widschwendter, Martin, Prof. | Prognostische und diagnostische Marker für Zell-proliferative Erkrankungen von Brustgeweben |
| EP2380993B1 (en) | 2004-03-08 | 2015-12-23 | Rubicon Genomics, Inc. | Method for generating and amplifying DNA libraries for sensitive detection and analysis of DNA methylation |
| WO2006128192A2 (en) | 2005-05-27 | 2006-11-30 | John Wayne Cancer Institute | Use of free circulating dna for diagnosis, prognosis, and treatment of cancer |
| US7901884B2 (en) * | 2006-05-03 | 2011-03-08 | The Chinese University Of Hong Kong | Markers for prenatal diagnosis and monitoring |
| US7754428B2 (en) * | 2006-05-03 | 2010-07-13 | The Chinese University Of Hong Kong | Fetal methylation markers |
| CN101153336B (zh) * | 2006-09-27 | 2011-09-07 | 香港中文大学 | 检测dna甲基化程度的方法和试剂盒 |
| WO2008155549A2 (en) | 2007-06-19 | 2008-12-24 | Oncomethylome Sciences Sa | Improved urine sample collecting and processing |
| US12054776B2 (en) | 2007-07-23 | 2024-08-06 | The Chinese University Of Hong Kong | Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing |
| JP4347372B2 (ja) | 2007-08-10 | 2009-10-21 | トヨタ自動車株式会社 | 静電塗装装置 |
| US20110028333A1 (en) * | 2009-05-01 | 2011-02-03 | Brown University | Diagnosing, prognosing, and early detection of cancers by dna methylation profiling |
| US8563242B2 (en) * | 2009-08-11 | 2013-10-22 | The Chinese University Of Hong Kong | Method for detecting chromosomal aneuploidy |
| WO2011038507A1 (en) * | 2009-10-02 | 2011-04-07 | Centre For Addiction And Mental Health | Method for analysis of dna methylation profiles of cell-free circulating dna in bodily fluids |
| LT3241914T (lt) * | 2009-11-05 | 2019-04-25 | The Chinese University Of Hong Kong | Vaisiaus genomo analizė iš motinos biologinio mėginio |
| CA2780016C (en) | 2009-11-06 | 2017-09-19 | The Chinese University Of Hong Kong | Size-based genomic analysis |
| AU2011207544A1 (en) * | 2010-01-19 | 2012-09-06 | Verinata Health, Inc. | Identification of polymorphic sequences in mixtures of genomic DNA by whole genome sequencing |
| EP2529032B1 (en) † | 2010-01-26 | 2017-01-25 | Nipd Genetics Ltd | Methods and compositions for noninvasive prenatal diagnosis of fetal aneuploidies |
| JP6073217B2 (ja) † | 2010-04-29 | 2017-02-08 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | ゲノムモデルに関するデータ統合を用いたパスウェイ認識アルゴリズム（ｐａｒａｄｉｇｍ） |
| GB201007944D0 (en) * | 2010-05-12 | 2010-06-30 | Univ Aberystwyth | Methods |
| ES2581594T3 (es) | 2010-05-25 | 2016-09-06 | The Johns Hopkins University | Composiciones y métodos para detectar una neoplasia |
| SG10201505723UA (en) * | 2010-07-23 | 2015-09-29 | Harvard College | Methods for detecting signatures of disease or conditions in bodily fluids |
| EP2596127A2 (en) * | 2010-07-23 | 2013-05-29 | Esoterix Genetic Laboratories, LLC | Identification of differentially represented fetal or maternal genomic regions and uses thereof |
| WO2012031329A1 (en) | 2010-09-10 | 2012-03-15 | Murdoch Childrens Research Institute | Assay for detection and monitoring of cancer |
| KR102040307B1 (ko) † | 2010-11-30 | 2019-11-27 | 더 차이니즈 유니버시티 오브 홍콩 | 암과 연관된 유전적 또는 분자적 이상들의 검출 |
| HUE053822T2 (hu) * | 2012-09-20 | 2021-07-28 | Univ Hong Kong Chinese | Nem invazív módszer daganat metilom meghatározása plazmából |
-
2013
- 2013-09-20 HU HUE17202149A patent/HUE053822T2/hu unknown
- 2013-09-20 PL PL22171427.2T patent/PL4056712T3/pl unknown
- 2013-09-20 DK DK22171427.2T patent/DK4056712T3/da active
- 2013-09-20 ES ES24153604T patent/ES3060911T3/es active Active
- 2013-09-20 PH PH1/2022/552061A patent/PH12022552061A1/en unknown
- 2013-09-20 HR HRP20240210TT patent/HRP20240210T1/hr unknown
- 2013-09-20 KR KR1020207019527A patent/KR102307424B1/ko active Active
- 2013-09-20 ES ES19171630T patent/ES2969567T3/es active Active
- 2013-09-20 ES ES22171427T patent/ES2994426T3/es active Active
- 2013-09-20 ES ES17202149T patent/ES2862726T3/es active Active
- 2013-09-20 EP EP19171630.7A patent/EP3536807B1/en active Active
- 2013-09-20 EP EP13838770.9A patent/EP2898100B9/en active Active
- 2013-09-20 SG SG11201501927VA patent/SG11201501927VA/en unknown
- 2013-09-20 CN CN202311671688.1A patent/CN117757932A/zh active Pending
- 2013-09-20 EP EP22171427.2A patent/EP4056712B1/en active Active
- 2013-09-20 WO PCT/AU2013/001088 patent/WO2014043763A1/en not_active Ceased
- 2013-09-20 SM SM20210256T patent/SMT202100256T1/it unknown
- 2013-09-20 FI FIEP19171630.7T patent/FI3536807T3/fi active
- 2013-09-20 DK DK17202149.5T patent/DK3354747T3/da active
- 2013-09-20 MY MYPI2018000607A patent/MY187444A/en unknown
- 2013-09-20 NZ NZ717423A patent/NZ717423A/en unknown
- 2013-09-20 PL PL24153604.4T patent/PL4335929T3/pl unknown
- 2013-09-20 PL PL19171630.7T patent/PL3536807T3/pl unknown
- 2013-09-20 BR BR122021021823-4A patent/BR122021021823B1/pt active IP Right Grant
- 2013-09-20 IL IL313451A patent/IL313451A/en unknown
- 2013-09-20 AU AU2013317708A patent/AU2013317708C1/en active Active
- 2013-09-20 KR KR1020157010184A patent/KR102148547B1/ko active Active
- 2013-09-20 EP EP21151739.6A patent/EP3839065A1/en active Pending
- 2013-09-20 PT PT221714272T patent/PT4056712T/pt unknown
- 2013-09-20 CN CN201380058654.3A patent/CN104781422B/zh active Active
- 2013-09-20 BR BR122021021825-0A patent/BR122021021825B1/pt active IP Right Grant
- 2013-09-20 BR BR112015006183-4A patent/BR112015006183B1/pt active IP Right Grant
- 2013-09-20 LT LTEP17202149.5T patent/LT3354747T/lt unknown
- 2013-09-20 DK DK19171630.7T patent/DK3536807T3/da active
- 2013-09-20 ES ES13838770T patent/ES2665273T5/es active Active
- 2013-09-20 KR KR1020217030373A patent/KR102390711B1/ko active Active
- 2013-09-20 EP EP24153604.4A patent/EP4335929B1/en active Active
- 2013-09-20 CA CA2884066A patent/CA2884066C/en active Active
- 2013-09-20 PL PL17202149T patent/PL3354747T3/pl unknown
- 2013-09-20 PH PH1/2015/500547A patent/PH12015500547B1/en unknown
- 2013-09-20 SG SG10201705198UA patent/SG10201705198UA/en unknown
- 2013-09-20 PT PT172021495T patent/PT3354747T/pt unknown
- 2013-09-20 LT LTEP22171427.2T patent/LT4056712T/lt unknown
- 2013-09-20 NZ NZ706269A patent/NZ706269A/en unknown
- 2013-09-20 PT PT191716307T patent/PT3536807T/pt unknown
- 2013-09-20 SI SI201332088T patent/SI4056712T1/sl unknown
- 2013-09-20 EP EP17202149.5A patent/EP3354747B1/en not_active Revoked
- 2013-09-20 HU HUE22171427A patent/HUE068129T2/hu unknown
- 2013-09-20 HU HUE19171630A patent/HUE066054T2/hu unknown
- 2013-09-20 FI FIEP22171427.2T patent/FI4056712T3/fi active
- 2013-09-20 KR KR1020237033920A patent/KR20230145530A/ko not_active Ceased
- 2013-09-20 EA EA201500327A patent/EA201500327A1/ru unknown
- 2013-09-20 CA CA3122779A patent/CA3122779A1/en active Pending
- 2013-09-20 IL IL299444A patent/IL299444B2/en unknown
- 2013-09-20 KR KR1020227013227A patent/KR102587176B1/ko active Active
- 2013-09-20 DK DK13838770.9T patent/DK2898100T4/da active
- 2013-09-20 PT PT138387709T patent/PT2898100T/pt unknown
- 2013-09-20 JP JP2015532250A patent/JP6317354B2/ja active Active
- 2013-09-20 MX MX2015003571A patent/MX360034B/es active IP Right Grant
- 2013-09-20 HR HRP20241142TT patent/HRP20241142T1/hr unknown
- 2013-09-20 MY MYPI2015000628A patent/MY173356A/en unknown
- 2013-09-20 PL PL13838770.9T patent/PL2898100T5/pl unknown
- 2013-09-23 TW TW109112451A patent/TWI784258B/zh active
- 2013-09-23 TW TW112118074A patent/TWI901957B/zh active
- 2013-09-23 TW TW102134227A patent/TWI640634B/zh active
- 2013-09-23 TW TW111119079A patent/TWI806621B/zh active
- 2013-09-23 TW TW114135706A patent/TW202605158A/zh unknown
- 2013-09-23 TW TW107123815A patent/TWI707953B/zh active
-
2015
- 2015-03-02 IL IL237495A patent/IL237495B/en active IP Right Grant
- 2015-03-16 ZA ZA2015/01772A patent/ZA201501772B/en unknown
-
2017
- 2017-10-27 AU AU2017251832A patent/AU2017251832B2/en active Active
-
2018
- 2018-03-28 JP JP2018061744A patent/JP6683752B2/ja active Active
-
2019
- 2019-08-05 IL IL268512A patent/IL268512B2/en unknown
-
2020
- 2020-01-08 AU AU2020200128A patent/AU2020200128B2/en active Active
- 2020-03-26 JP JP2020055387A patent/JP6985753B2/ja active Active
-
2021
- 2021-05-07 HR HRP20210716TT patent/HRP20210716T1/hr unknown
- 2021-05-14 CY CY20211100417T patent/CY1124139T1/el unknown
- 2021-11-18 JP JP2021188060A patent/JP2022031753A/ja active Pending
-
2022
- 2022-02-16 AU AU2022201026A patent/AU2022201026B2/en active Active
-
2023
- 2023-09-28 JP JP2023167714A patent/JP7594817B2/ja active Active
-
2024
- 2024-11-18 JP JP2024200780A patent/JP2025026936A/ja active Pending
-
2025
- 2025-07-03 AU AU2025205087A patent/AU2025205087A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX360034B (es) | Determinacion no invasiva del metiloma fetal o de tumor de plasma. | |
| Vachon et al. | Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk | |
| CY1121828T1 (el) | Αναλυση βασει μεγεθους θραυσματος εμβρυϊκου dna στο μητρικο πλασμα | |
| CY1121741T1 (el) | Χρηση του μεγεθους θραυσματων εξωκυτταριου dna για τον προσδιορισμο παραλλαγης αριθμου αντιγραφων | |
| CY1118864T1 (el) | Μεθοδοι και συνθεσεις για μη επεμβατικη προγεννητικη διαγνωση εμβρυϊκων ανευπλοειδιων | |
| MX2010000846A (es) | Diagnostico de aneuploide cromosomico fetal mediante el uso de secuenciacion genomica. | |
| MY195999A (en) | Molecular Detection/Diagnosis Reagent for Tumor | |
| MX2017006670A (es) | Metodos y composiciones para la modificacion genetica dirigida mediante el uso de arn guia combinados. | |
| MX2013012167A (es) | Estratificaciones a base de bcma y terapia para pacientes con mieloma multiple. | |
| WO2016138105A3 (en) | Assays to determine dna methylation and dna methylation markers of cancer | |
| EA201400117A1 (ru) | Способы и нуклеиновые кислоты для определения прогноза у больных раком | |
| MX2017014381A (es) | Metodos terapeuticos y diagnosticos para cancer. | |
| ES2721051T3 (es) | Método para la evaluación no invasiva de variaciones genéticas | |
| EP3572529A3 (en) | Gene methylation based colorectal cancer diagnosis | |
| MX2015004610A (es) | Metodo para diagnostico, pronostico y tratamiento de metastasis de cancer de prostata usando c-maf. | |
| CY1122030T1 (el) | Μεθοδος εκτιμησης της ποσοτητας μεθυλιωμενου τοπου σε ενα δειγμα | |
| NZ748624A (en) | Methods of selecting an individual who will benefit from treatment with a telomerase inhibitor using a formalin fixed paraffin embedded (ffpe) biological sample of solid tumor cancer cells | |
| BR112018003799A2 (pt) | marcadores de diagnósticos moleculares zic1 e ghsr para cânceres invasivos induzidos por hpv, cânceres ginecológicos e anogenitais induzidos por não-hpv e suas lesões precursoras de alto grau | |
| MX2019010508A (es) | Clasificador de metilacion para detectar canceres invasivos inducidos por vph, canceres ginecologicos y anogenitales no inducidos por vph y sus lesiones precursoras de alto grado. | |
| CY1124409T1 (el) | Μεθοδος μη επεμβατικης προγεννητικης ανιχνευσης της ανευπλοειδιας του εμβρυικου χρωμοσωματος απο το μητρικο αιμα με βαση τη μεθοδο του βayes | |
| ES2672989T3 (es) | FALZ para su uso como diana para terapias para tratar el cáncer | |
| MX382589B (es) | Determinación no invasiva del metiloma fetal o de tumor de plasma. | |
| WO2019103421A3 (ko) | 유전자의 cpg 메틸화 변화를 이용한 간암의 예후 또는 위험도를 평가하는 방법 | |
| PE20142434A1 (es) | Metodo para la identificacion del origen de un cancer de origen primario desconocido | |
| JIANG et al. | Genotyping of human papillomavirus in male patients with anogenital warts in Lishui area, Zhejiang province |